Department of Otorhinolaryngology-Head and Neck Surgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Gyeonggi-do, 13496, Republic of Korea.
Surg Oncol. 2022 May;41:101734. doi: 10.1016/j.suronc.2022.101734. Epub 2022 Mar 2.
Cervical schwannomas are rare diseases treated by complete resection, leading to potential neurological deficits. Intracapsular enucleation is an acceptable alternative to preserve the involved nerve function, but the clinical outcomes by an aesthetically pleasing approach remain unrevealed. This study evaluated functional and oncological outcomes after intracapsular enucleation of cervical schwannomas via retroauricular hairline (Roh's) incision.
This prospective observational study included 17 patients with cervical schwannomas who underwent intracapsular enucleation to preserve the involved nerve and capsule via Roh's incision. Each patient was evaluated with any complications, nerve function, subjective satisfaction, voice and swallowing questionnaires, and local recurrence.
Intracapsular enucleation via the Roh's incision was successfully applied to all patients for a median operation time of 48 min. Tumours of 4.5-cm median size were removed with the minimization of injury to the nerve and sheath deflected on the surface of the tumour. Temporary and permanent paralysis of the unilateral vocal fold was found in 3 (33%) and none of 9 patients with vagal schwannomas, respectively. Horner's syndrome occurred temporarily in two of 5 (40%) patients with sympathetic chain schwannomas. Postoperative complications were minor. Subjective satisfaction of scar and facial deformity was high, and subjective voice and swallowing difficulties were minimal one year after surgery. No recurrence was found in the patients for a median follow-up of 82 months.
Intracapsular enucleation via Roh's incision is a viable treatment for cervical schwannomas with the highest functional, cosmetic, and oncological outcomes.
颈椎神经鞘瘤是一种罕见疾病,通常通过完全切除进行治疗,这可能导致潜在的神经功能缺损。囊内切除术是一种可接受的替代方法,可以保留受累神经的功能,但在美学上令人满意的方法的临床结果仍未得到揭示。本研究通过耳后发际内(Roh's)切口评估颈椎神经鞘瘤囊内切除术的功能和肿瘤学结果。
这是一项前瞻性观察研究,纳入了 17 例通过 Roh's 切口行囊内切除术保留受累神经和包膜的颈椎神经鞘瘤患者。每位患者均评估了任何并发症、神经功能、主观满意度、声音和吞咽问卷以及局部复发情况。
通过 Roh's 切口成功应用囊内切除术治疗所有患者,中位手术时间为 48 分钟。肿瘤大小中位数为 4.5cm,最大程度地减少了对神经和鞘的损伤,并使神经和鞘在肿瘤表面发生偏曲。9 例迷走神经鞘瘤患者中有 3 例(33%)出现单侧声带暂时性和永久性瘫痪,5 例交感神经鞘瘤患者中无一例出现永久性瘫痪。2 例交感神经鞘瘤患者出现暂时性霍纳综合征。术后并发症轻微。患者对疤痕和面部畸形的主观满意度高,术后 1 年主观声音和吞咽困难最小。17 例患者的中位随访时间为 82 个月,无复发。
通过 Roh's 切口行囊内切除术是治疗颈椎神经鞘瘤的一种可行方法,可获得最高的功能、美容和肿瘤学结果。